Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

Blood (2024) 143 (14): 1399–1413.

https://doi.org/10.1182/blood.2023021349

Published: 2024

Includes: Supplemental data

Journal Articles

First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis

Blood (2023) 142 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2023-189094

Published: 2023

Journal Articles

Deciphering the Immune Microenvironment in Waldenstrom's Macroglobulinemia

Blood (2023) 142 (Supplement 1): 4690.

https://doi.org/10.1182/blood-2023-188408

Published: 2023

Journal Articles

Remodeling of the Immune Microenvironment By Oncogenic MYD88 Dictates Immunotherapy Responses across Indolent and Aggressive B-Cell Lymphomas

Jon Celay, Miriam Recalde, María Victoria Revuelta, Marta Larrayoz, Sara Rodriguez, Maria J Garcia-Barchino, Jennifer R. Chapman-Fredricks, Teresa Lozano, Juan J Lasarte, Ming Q. Du, Izidore S. Lossos, Sergio Roa, Aldo Roccaro, Miguel Canales, Felipe Prosper, Bruno Paiva, Leandro Cerchietti, Jose A. Martinez-Climent

Blood (2023) 142 (Supplement 1): 431.

https://doi.org/10.1182/blood-2023-173394

Published: 2023

Journal Articles

Biological and Clinical Significance of Undetectable Circulating Tumor Cells (CTCs) in Patients (Pts) with Multiple Myeloma (MM)

Blood (2023) 142 (Supplement 1): 646.

https://doi.org/10.1182/blood-2023-186411

Published: 2023

Journal Articles

3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients

Blood (2023) 142 (Supplement 1): 3165.

https://doi.org/10.1182/blood-2023-177619

Published: 2023

Journal Articles

The Use of Next Generation Flow in Multiple Myeloma Patients: A Preliminary Real-Life Multicenter MRD Harmonization Experience

Blood (2023) 142 (Supplement 1): 7161.

https://doi.org/10.1182/blood-2023-186536

Published: 2023

Journal Articles

Failure to Achieve Sustained Imaging MRD Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Is Associated with Adverse Prognosis in Newly Diagnosed Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation Followed By Maintenance Therapy

Angelo Belotti, Rossella Ribolla, Claudia Crippa, Marco Chiarini, Viviana Giustini, Samantha Ferrari, Annalisa Peli, Chiara Cattaneo, Aldo Roccaro, Barbara Frittoli, Marta Salis, Luigi Grazioli, Giuseppe Rossi, Alessandra Tucci

Blood (2022) 140 (Supplement 1): 1140–1141.

https://doi.org/10.1182/blood-2022-157520

Published: 2022

Journal Articles

Long Noncoding RNA LINC01410 Interacts with the Minichromosome Maintenance (MCM) Complex to Promote Tumor Cell Growth in Multiple Myeloma

Doriana Gramegna, Na Liu, Yao Yao, Megan Johnstone, Domenico Maisano, Annamaria Gulla, Anil Aktas-Samur, Aldo Roccaro, Mehmet K. Samur, Mariateresa Fulciniti, Eugenio Morelli, Nikhil C Munshi

Blood (2022) 140 (Supplement 1): 4191–4192.

https://doi.org/10.1182/blood-2022-169185

Published: 2022

Journal Articles

Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma

Blood (2017) 129 (16): 2233–2245.

https://doi.org/10.1182/blood-2016-06-724831

Published: 2017

Includes: Supplemental data

Journal Articles

Targeting NAD + salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

Michele Cea, Antonia Cagnetta, Mariateresa Fulciniti, Yu-Tzu Tai, Teru Hideshima, Dharminder Chauhan, Aldo Roccaro, Antonio Sacco, Teresa Calimeri, Francesca Cottini, Jana Jakubikova, Sun-Young Kong, Franco Patrone, Alessio Nencioni, Marco Gobbi, Paul Richardson, Nikhil Munshi, Kenneth C. Anderson

Blood (2012) 120 (17): 3519–3529.

https://doi.org/10.1182/blood-2012-03-416776

Published: 2012

Includes: Supplemental data

Journal Articles

Proteomic Analysis of Multiple Myeloma Identifies Upregulation of CRIK Protein, a Novel Protein Regulating Migration and Adhesion

Hai T. Ngo, Evdoxia Hatjiharissi, MD, Alexey A. Leontovich, PhD, Wee Chng, PhD, Mena Farag, Xavier Leleu, MD, PhD, Xiaoying Jia, Judith Runnels, PhD, Aldo Roccaro, MD, PhD, Abdel Kareem Azab, PhD, Feda Azab, Antonio Sacco, Nicholas Burwick, MD, Molly R. Melhem, Kenneth C. Anderson, MD, Rafael Fonseca, MD, Thomas E. Witzig, MD, Irene M. Ghobrial, MD

Blood (2008) 112 (11): 643.

https://doi.org/10.1182/blood.V112.11.643.643

Published: 2008

Journal Articles

SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia

Hai T. Ngo, Xavier Leleu, Jack Lee, Xiaoying Jia, Molly Melhem, Judith Runnels, Anne-Sophie Moreau, Nicholas Burwick, Abdel Kareem Azab, Aldo Roccaro, Feda Azab, Antonio Sacco, Mena Farag, Robert Sackstein, Irene M. Ghobrial

Blood (2008) 112 (1): 150–158.

https://doi.org/10.1182/blood-2007-12-129395

Published: 2008

Journal Articles

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

Blood (2007) 110 (13): 4417–4426.

https://doi.org/10.1182/blood-2007-05-092098

Published: 2007

Journal Articles

The Interaction of CXCR4/SDF-1 and VLA-4 Regulates Adhesion and Transendothelial Migration in Waldenstrom Macroglobulinemia.

Hai T. Ngo, Mena Farag, Xavier Leleu, Xiaoying Jia, Judith Runnels, Anne-Sophie Moreau, Abdelkareem Azab, Feda Azab, Evdoxia Hatjiharissi, Aldo Roccaro, Antonio Sacco, Irene M. Ghobrial

Blood (2007) 110 (11): 2617.

https://doi.org/10.1182/blood.V110.11.2617.2617

Published: 2007

Journal Articles

The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).

Aldo Roccaro, MD, Xavier Leleu, MD, Antonio Sacco, Xiaoying Jia, Anne-Sophie Moreau, MD, Hai Ngo, Abdelkareem Azab, Feda Azab, Evdoxia Hatjiharissi, MD, Steven Treon, MD, Teru Hideshima, MD, Michael Palladino, Kenneth Anderson, MD, Dharminder Chuahan, Irene Ghobrial, MD

Blood (2007) 110 (11): 1516.

https://doi.org/10.1182/blood.V110.11.1516.1516

Published: 2007

Journal Articles

Comprehensive Molecular Characterization of Malignant and Microenvironmental Cells in Waldenstrom’s Macroglobulinemia by Gene Expression Profiling.

Evdoxia Hatjiharissi, MD, Constantine S. Mitsiades, MD,Ph.D, Ciccarelli T. Bryan, Xu Lian, Cao Yang, Sophia Adamia, Ph.D, Xavier Leleu, MD, Aldo Roccaro, MD, Leukothea Ioakimidis, Zachary R. Hunter, Christopher J. Patterson, Irene Ghobrial, MD, Steven P. Treon, MD,Ph.D

Blood (2007) 110 (11): 3174.

https://doi.org/10.1182/blood.V110.11.3174.3174

Published: 2007

Journal Articles

Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia.

Aldo Roccaro, MD, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Antonio Sacco, Lian Xu, Evdoxia Hatjiharissi, MD, Bryan Ciccarelli, Christopher Patterson, Sophia Adamia, Domenico Russo, MD, Angelo Vacca, MD, Franco Dammacco, MD, Kenneth Anderson, MD, Irene Ghobrial, MD, Steven Treon, MD

Blood (2007) 110 (11): 1383.

https://doi.org/10.1182/blood.V110.11.1383.1383

Published: 2007

Journal Articles

Biological Sequelae of TRAF2 Downregulation in Waldenstrom Macroglobulinemia Cells.

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Sophia Adamia, PhD, Evdoxia Hatjiharissi, MD, Anne-Sophie Moreau, MD, Aldo Roccaro, MD, Antonio Sacco, MD, Brian Ciccarelli, Robert J. Manning, Christopher J. Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2007) 110 (11): 3526.

https://doi.org/10.1182/blood.V110.11.3526.3526

Published: 2007

Journal Articles

Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma

Noopur Raje, Shaji Kumar, Teru Hideshima, Aldo Roccaro, Kenji Ishitsuka, Hiroshi Yasui, Norihiko Shiraishi, Dharminder Chauhan, Nikhil C. Munshi, Simon R. Green, Kenneth C. Anderson

Blood (2005) 106 (3): 1042–1047.

https://doi.org/10.1182/blood-2005-01-0320

Published: 2005

NARROW

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis

Deciphering the Immune Microenvironment in Waldenstrom's Macroglobulinemia

Remodeling of the Immune Microenvironment By Oncogenic MYD88 Dictates Immunotherapy Responses across Indolent and Aggressive B-Cell Lymphomas

Biological and Clinical Significance of Undetectable Circulating Tumor Cells (CTCs) in Patients (Pts) with Multiple Myeloma (MM)

3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients

The Use of Next Generation Flow in Multiple Myeloma Patients: A Preliminary Real-Life Multicenter MRD Harmonization Experience

Failure to Achieve Sustained Imaging MRD Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Is Associated with Adverse Prognosis in Newly Diagnosed Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation Followed By Maintenance Therapy

Long Noncoding RNA LINC01410 Interacts with the Minichromosome Maintenance (MCM) Complex to Promote Tumor Cell Growth in Multiple Myeloma

Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma

Targeting NAD + salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

Proteomic Analysis of Multiple Myeloma Identifies Upregulation of CRIK Protein, a Novel Protein Regulating Migration and Adhesion

SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

The Interaction of CXCR4/SDF-1 and VLA-4 Regulates Adhesion and Transendothelial Migration in Waldenstrom Macroglobulinemia.

The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).

Comprehensive Molecular Characterization of Malignant and Microenvironmental Cells in Waldenstrom’s Macroglobulinemia by Gene Expression Profiling.

Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia.

Biological Sequelae of TRAF2 Downregulation in Waldenstrom Macroglobulinemia Cells.

Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only